Gene · 54210
Papers3,294
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 3,294
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Proteome-wide Mendelian randomization identifies causal plasma proteins in frontotemporal dementia. | Neurol Sci | 2026 | 42498838 | PubTator, text mining | PubMed |
| TREM1 unleashes immunosuppression in glioma: targeting macrophage polarization as a new therapeutic vulnerability. | Front Immunol | 2026 | 42491234 | PubTator, text mining | PubMed |
| Liquiritigenin attenuates aneurysm progression and local inflammatory activation in a rabbit common carotid artery aneurysm model. | Eur J Pharmacol | 2026 | 42476437 | PubTator, text mining | PubMed |
| Multiomics integrative bioinformatics analysis of gene expression characteristics and molecular mechanisms in preeclampsia placental tissue. | Artif Cells Nanomed Biotechnol | 2026 | 42473750 | PubTator, text mining | PubMed |
| Microglia heterogeneity in vascular dementia pathology. | iScience | 2026 | 42473665 | PubTator, text mining | PubMed |
| Recent advances in early screening and diagnosis of sepsis: a narrative review. | Front Cell Infect Microbiol | 2026 | 42459343 | PubTator, text mining | PubMed |
| TREM1 signaling amplifies neutrophil-mediated inflammation in inflammatory bowel disease. | Nat Commun | 2026 | 42420283 | PubTator, text mining | PubMed |
| TREM1-mediated macrophage activation drives voriconazole-induced hepatic steatosis: Diagnostic and therapeutic implications. | J Pharm Anal | 2026 | 42403941 | PubTator, text mining | PubMed |
A transcriptome-defined TAM-rich phenotype identifies a macrophage-enriched, hypoxia-linked immune contexture in glioblastoma: multi-cohort transcriptomic validation and local histopathological correlation. | Front Immunol | 2026 | 42389535 | PubTator, text mining | PubMed |
| Plasma and urinary sTREM-1 as biomarkers of sepsis-associated acute kidney injury in critically Ill children. | Eur J Pediatr | 2026 | 42377559 | PubTator, text mining | PubMed |
| The role of the mesenchymal stem cell therapy in bone regeneration of osteoporosis: clinical translation and limitations. | Int Immunopharmacol | 2026 | 42330581 | PubTator, text mining | PubMed |
| Beyond Hemostasis: Platelet Biomarkers and Vascular-Immune Crosstalk in Dengue. | FASEB J | 2026 | 42328715 | PubTator, text mining | PubMed |
| Unraveling the role of HIF-1 in peripheral blood mononuclear cells from older patients with Alzheimer's disease. | Front Aging Neurosci | 2026 | 42318557 | PubTator, text mining | PubMed |
| Circadian-immune-related gene signature for lung squamous cell carcinoma: machine learning and multi-omics analysis. | Transl Cancer Res | 2026 | 42305521 | PubTator, text mining | PubMed |
| Monitoring Inflammatory Markers and Anti-α-Gal Antibodies in Liver Transplant Recipients: Implications for Infection and Rejection. | Diagnostics (Basel) | 2026 | 42279503 | PubTator, text mining | PubMed |
| TREM1+ Neutrophils Determine Immunosuppressive Microenvironment and Immunotherapy Response in Hepatocellular Carcinoma. | Liver Int | 2026 | 42244441 | PubTator, text mining | PubMed |
| Rheumatoid arthritis synovial fibroblasts promote the glycolysis of myeloid-derived suppressor cells via TREM1/mTOR axis. | Int Immunopharmacol | 2026 | 42242136 | PubTator, text mining | PubMed |
| Association of TREM1 expression with mTOR and DRP1 in gallbladder cancer: a study of 105 cases. | World J Surg Oncol | 2026 | 42174658 | PubTator, text mining | PubMed |
Overexpression of TREM1 predicts poor prognosis and chemotherapy resistance in Egyptian acute myeloid leukemia associated with FLT3 internal tandem duplication and CD123 expression and stemness signatures. | Discov Oncol | 2026 | 42133230 | PubTator, text mining | PubMed |
| Plasma soluble TREM-1 and risk of cardiovascular disease in the population. Results from the Paris Prospective Study III and the CoLaus|PsyCoLaus. | Eur J Prev Cardiol | 2026 | 42119151 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/54210/papers?page=2